• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院特定因素影响慢性肾脏病患者的血压治疗质量。

Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.

作者信息

van Zuilen A D, Blankestijn P J, van Buren M, Ten Dam M A G J, Kaasjager K A H, Ligtenberg G, Sijpkens Y W J, Sluiter H E, van de Ven P J G, Vervoort G, Vleming L, Bots M L, Wetzels J F M

机构信息

Department of Nephrology, University Medical Center Utrecht, Utrecht, the Netherlands.

出版信息

Neth J Med. 2011 May;69(5):229-36.

PMID:21646672
Abstract

BACKGROUND

Blood pressure (BP) is the most important modifiable risk factor for cardiovascular (CV) disease and progression of kidney dysfunction in patients with chronic kidney disease. Despite extensive antihypertensive treatment possibilities, adequate control is notoriously hard to achieve. Several determinants have been identified which affect BP control. In the current analysis we evaluated differences in achieved BP and achievement of the BP goal between hospitals and explored possible explanations.

METHODS

At baseline, BP was measured in a supine position with an oscillometric device in 788 patients participating in the MASTER PLAN study. We also retrieved the last measured office BP from the patient records. Additional baseline characteristics were derived from the study database. Univariate and multivariate analyses were performed with general linear modelling using hospital as a random factor.

RESULTS

In univariate analysis, hospital was a determinant of the level of systolic and diastolic BP at baseline. Adjustment for patient, kidney disease, treatment or hospital characteristics affected the relation. Yet, in a fully adjusted model, differences between centres persisted with a range of 15 mmHg for systolic BP and 11 mmHg for diastolic BP.

CONCLUSION

Despite extensive adjustments, a clinically relevant, statistically significant difference between hospitals was found in standardised BP measurements at baseline of a randomised controlled study. We hypothesise that differences in the approach towards BP control exist at the physician level and that these explain the differences between hospitals.

摘要

背景

血压(BP)是心血管疾病(CV)以及慢性肾病患者肾功能不全进展的最重要的可改变风险因素。尽管有广泛的抗高血压治疗方法,但众所周知,要实现充分控制却很困难。已经确定了几个影响血压控制的决定因素。在当前的分析中,我们评估了不同医院之间血压控制情况以及血压目标达成情况的差异,并探讨了可能的原因。

方法

在基线时,使用示波装置对参与MASTER PLAN研究的788名患者进行仰卧位血压测量。我们还从患者记录中获取了最后一次测量的诊室血压。其他基线特征来自研究数据库。使用医院作为随机因素,通过一般线性模型进行单变量和多变量分析。

结果

在单变量分析中,医院是基线时收缩压和舒张压水平的一个决定因素。对患者、肾病、治疗或医院特征进行调整会影响这种关系。然而,在一个完全调整的模型中,各中心之间的差异仍然存在,收缩压相差15 mmHg,舒张压相差11 mmHg。

结论

尽管进行了广泛的调整,但在一项随机对照研究的基线标准化血压测量中,发现不同医院之间存在具有临床相关性且具有统计学意义的差异。我们推测在医生层面存在血压控制方法的差异,这解释了不同医院之间的差异。

相似文献

1
Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.医院特定因素影响慢性肾脏病患者的血压治疗质量。
Neth J Med. 2011 May;69(5):229-36.
2
Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).缬沙坦治疗高血压的有效性:患者特征分析及决定因素与结局的分层建模(PREVIEW研究)
Ann Pharmacother. 2009 May;43(5):849-61. doi: 10.1345/aph.1L576. Epub 2009 Apr 7.
3
The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.家庭血压评估和联合降压治疗在实现目标血压控制方面的治疗重要性:茨城县高血压评估试验。
Hypertens Res. 2010 Dec;33(12):1264-71. doi: 10.1038/hr.2010.175. Epub 2010 Oct 7.
4
[Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].[全科医疗与高血压最佳治疗(HOT)研究中的血压控制质量。法国HOT研究小组(高血压最佳治疗)]
Arch Mal Coeur Vaiss. 1995 Aug;88(8):1179-81.
5
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
6
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.动态血压与诊室血压用于评估临床试验中抗高血压疗效:来自Val-Syst研究的见解
Clin Ther. 2004 Sep;26(9):1436-45. doi: 10.1016/j.clinthera.2004.09.003.
7
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.高血压强化与固定复方治疗的血压反应预测因素:ACCOMPLISH研究
Blood Press. 2008;17(1):7-17. doi: 10.1080/08037050801972857.
8
On-treatment diastolic blood pressure and prognosis in systolic hypertension.收缩期高血压治疗期间的舒张压与预后
Arch Intern Med. 2007 Sep 24;167(17):1884-91. doi: 10.1001/archinte.167.17.1884.
9
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
10
Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study).韩国基层医生高血压治疗的现状与特点:来自韩国高血压流行病学研究(KEY研究)的数据。
Am J Hypertens. 2008 Aug;21(8):884-9. doi: 10.1038/ajh.2008.191. Epub 2008 May 15.

引用本文的文献

1
Interventions for improving health literacy in people with chronic kidney disease.干预措施以提高慢性肾脏病患者的健康素养。
Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD012026. doi: 10.1002/14651858.CD012026.pub2.
2
Making audit actionable: an example algorithm for blood pressure management in chronic kidney disease.让审核具有可操作性:慢性肾脏病血压管理的一个示例算法
AMIA Annu Symp Proc. 2014 Nov 14;2014:343-52. eCollection 2014.
3
Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care.
医院在实现慢性肾脏病甲状旁腺激素治疗目标方面的差异并不反映护理质量的差异。
BMC Nephrol. 2012 Aug 6;13:82. doi: 10.1186/1471-2369-13-82.